Liabilities, Current in USD of Indaptus Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Indaptus Therapeutics, Inc. quarterly Liabilities, Current history and change rate from Q4 2020 to Q3 2025.
Indaptus Therapeutics, Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $2.23M, a 0.08% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Indaptus Therapeutics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$2.23M	+$1.85K	+0.08%	30 Sep 2025	10-Q	12 Nov 2025
Q2 2025	$8.51M	+$6.58M	+342%	30 Jun 2025	10-Q	13 Aug 2025
Q1 2025	$2.61M	+$1.07M	+69.9%	31 Mar 2025	10-Q	14 May 2025
Q4 2024	$3.39M	+$620K	+22.3%	31 Dec 2024	10-Q	12 Nov 2025
Q3 2024	$2.23M	-$133K	-5.61%	30 Sep 2024	10-Q	12 Nov 2024
Q2 2024	$1.93M	-$175K	-8.32%	30 Jun 2024	10-Q	12 Aug 2024
Q1 2024	$1.54M	-$285K	-15.6%	31 Mar 2024	10-Q	08 May 2024
Q4 2023	$2.77M	-$659K	-19.2%	31 Dec 2023	10-K	13 Mar 2025
Q3 2023	$2.37M	-$516K	-17.9%	30 Sep 2023	10-Q	06 Nov 2023
Q2 2023	$2.1M	-$1.52M	-42%	30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$1.82M	-$1.86M	-50.5%	31 Mar 2023	10-Q	11 May 2023
Q4 2022	$3.43M	-$1.17M	-25.4%	31 Dec 2022	10-K	13 Mar 2024
Q3 2022	$2.88M	-$2.9M	-50.2%	30 Sep 2022	10-Q	10 Nov 2022
Q2 2022	$3.62M	-$1.82M	-33.4%	30 Jun 2022	10-Q	08 Aug 2022
Q1 2022	$3.68M			31 Mar 2022	10-Q	12 May 2022
Q4 2021	$4.6M	+$2.59M	+128%	31 Dec 2021	10-K	17 Mar 2023
Q3 2021	$5.78M			30 Sep 2021	10-Q	15 Nov 2021
Q2 2021	$5.44M			30 Jun 2021	10-Q	16 Aug 2021
Q4 2020	$2.02M			31 Dec 2020	10-K	21 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.